Podocalyxin in Normal Tissue and Epithelial Cancer

Area of Science:

• Cell biology
• Oncology
• Biochemistry

Background:

• Podocalyxin (PODXL) is a cell surface sialomucin normally found in kidney podocytes and vascular endothelial cells.
• PODXL regulates cell adhesion and morphology in the kidney, crucial for organ development and function.
• Outside the kidney, PODXL has roles in tissue remodeling and development.

Purpose of the Study:

• To review the dual role of PODXL in normal tissue function and epithelial cancers.
• To focus on PODXL's involvement in cancer metastasis and chemoresistance.
• To evaluate PODXL as a potential diagnostic and prognostic biomarker.

Main Methods:

• Literature review of existing studies on PODXL.
• Analysis of PODXL expression patterns in normal tissues and various cancers.
• Synthesis of evidence linking PODXL to cancer progression and treatment outcomes.

Main Results:

• PODXL overexpression is common in epithelial cancers and correlates with poor prognosis.
• PODXL is implicated in promoting cancer cell metastasis.
• Evidence suggests PODXL may contribute to chemoresistance in tumors.

Conclusions:

• PODXL plays critical roles in both normal kidney physiology and cancer biology.
• Targeting PODXL may offer therapeutic strategies for epithelial cancers.
• PODXL shows promise as a biomarker for cancer diagnosis and prognosis.